This post was published by Jon Fleetwood. Support him by subscribing at Substack and following at Instagram / X / Facebook.
A healthy 74-year-old man died from toxic shock syndrome during Moderna’s Phase 1/2 clinical trial of its experimental mRNA-1018 pandemic influenza vaccine, according to a study published in April in Clinical Infectious Diseases by scientists from Moderna and collaborating institutions. The Moderna and collaborating scient…
Read with caution - this story is only being covered by one news source that has a ‘low factuality’ rating, which means the outlet has a history of poor reporting practices. Learn more about factuality ratings here.